Company Nutrimetadiab Srl with Fiscal Code 36807746
recorded a turnover of 2024 of
172.790,
with a net profit of
124.293
and having an average number of employees of
2.
The company operates in the field of Activităţi de asistenţă medicală specializată having the NACE code 8622.
Sales - Ron
Sales, Profit, Employees, Total Income, Financial Results -
Nutrimetadiab Srl
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Sales - EUR
-
0
14.749
47.155
70.369
101.103
119.870
140.173
150.564
172.790
Total Income - EUR
-
0
14.749
47.156
70.369
101.104
119.870
140.174
150.564
172.792
Total Expenses - EUR
-
0
8.438
17.559
22.129
23.200
27.280
31.534
39.924
44.092
Gross Profit/Loss - EUR
-
0
6.311
29.596
48.240
77.905
92.590
108.640
110.640
128.699
Net Profit/Loss - EUR
-
0
6.164
29.125
47.538
77.146
91.416
107.449
109.346
124.293
Employees
-
0
1
2
2
2
2
2
2
2
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded.
In the last year of activity, the sales increased by 15.4%, from 150.564 euro in the year 2023, to 172.790 euro in 2024.
The Net Profit increased by 15.559 euro, from 109.346 euro in 2023, to 124.293 in the last year.
Check the financial reports for the company - Nutrimetadiab Srl
Financial Rating - NUTRIMETADIAB SRL
See the company's note based on the submitted financial data, relative to the industry of which it is a part.
Financial Rating
Payment Limits - Nutrimetadiab Srl
See the company's payment capacity for situations in which you conclude contracts with payment terms.
Check Payment Limits
Prob. of insolvency - Nutrimetadiab Srl
It determines the risk of insolvency based on the submitted accounting balance.
Insolvency Probability
Financial Reports - Nutrimetadiab Srl
Check all the financial reports of the company and know the risks in collaboration with it.
Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of
121.219 euro in 2024 which includes Inventories of
0 euro, Receivables of
92.582 euro and cash availability of
28.637 euro.
The company's Equity was valued at
147.227 euro, while total Liabilities amounted to
3.256 euro.
Equity increased by 29.955 euro, from 117.931 euro in 2023, to 147.227 in 2024.
Similar services useful for checking companies and business development.
SellNet
Get the contact details for any company and get in touch with it.
Sectoral Studies
Knows the market and develops its own development strategies according to sectorial data.
Databases
Export in excel files the data of the companies selected according to the desired criteria.
Import - Export
Find importers and exporters according to the type of activity and the countries in which they carry it out.
Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.
Comments - Nutrimetadiab Srl